Phathom Pharmaceuticals Ownership 2024 | Who Owns Phathom Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

91.19%

Insider Ownership

9.07%

Retail Ownership

-0.27%

Institutional Holders

117.00

Phathom Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.17.64%4.53%10,109,279--107,360,543Mar 31, 2024
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD13.03%17.65%7,464,5723,703,70398.48%79,273,755Mar 31, 2024
CARLYLE GROUP INC.6.10%2.34%3,496,808--37,101,133Mar 31, 2024
INVESCO LTD.5.51%0.01%3,159,789-7,864-0.25%33,556,959Mar 31, 2024
BLACKROCK INC.4.79%0.00%2,745,38066,4892.48%29,155,935Mar 31, 2024
ENSIGN PEAK ADVISORS, INC3.98%0.04%2,280,000--24,213,600Mar 31, 2024
VANGUARD GROUP INC3.45%0.00%1,979,11322,6841.16%21,018,180Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC3.42%1.29%1,960,169--20,816,995Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP3.03%0.59%1,735,00013,4200.78%18,425,700Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC2.88%1.28%1,650,000370,00028.91%17,523,000Mar 31, 2024
JENNISON ASSOCIATES LLC2.88%0.01%1,647,6971,647,697100.00%17,498,542Mar 31, 2024
GILDER GAGNON HOWE & CO LLC1.78%0.14%1,017,617-437,515-30.07%10,807,093Mar 31, 2024
PROPEL BIO MANAGEMENT, LLC1.52%5.38%869,927426,88096.35%9,238,625Mar 31, 2024
DECHENG CAPITAL LLC1.48%1.21%850,000--9,027,000Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.31%0.00%751,37916,1062.19%7,980,977Mar 31, 2024
CATALYS PACIFIC, LLC1.26%5.18%721,962--7,667,236Mar 31, 2024
STATE STREET CORP1.25%0.00%717,20129,3644.27%7,616,675Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC1.00%0.13%572,3363600.06%6,078,208Mar 31, 2024
GW&K INVESTMENT MANAGEMENT, LLC0.99%0.05%568,0266,5361.16%6,032,000Mar 31, 2024
WOODLINE PARTNERS LP0.99%0.06%566,439-529,682-48.32%6,015,582Mar 31, 2024

Phathom Pharmaceuticals's largest institutional shareholder is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., holding 17.64% of the company's total share outstanding, currently valued at $107.36M. The top 10 institutional shareholders own together 63.85% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD13.03%17.65%7,464,5723,703,70398.48%79,273,755Mar 31, 2024
PROPEL BIO MANAGEMENT, LLC1.52%5.38%869,927426,88096.35%9,238,625Mar 31, 2024
CATALYS PACIFIC, LLC1.26%5.18%721,962--7,667,236Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.17.64%4.53%10,109,279--107,360,543Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.78%3.16%445,16185,71523.85%4,727,610Mar 31, 2024
CARLYLE GROUP INC.6.10%2.34%3,496,808--37,101,133Mar 31, 2024
SATURN V CAPITAL MANAGEMENT LLC0.87%2.13%500,987340,912212.97%5,320,482Mar 31, 2024
GHOST TREE CAPITAL, LLC0.85%1.43%485,00099,75925.90%5,150,700Mar 31, 2024
PENN MUTUAL ASSET MANAGEMENT, LLC0.11%1.42%62,802--666,957Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC3.42%1.29%1,960,169--20,816,995Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC2.88%1.28%1,650,000370,00028.91%17,523,000Mar 31, 2024
DECHENG CAPITAL LLC1.48%1.21%850,000--9,027,000Mar 31, 2024
STEPSTONE GROUP LP0.74%0.95%422,085--4,482,543Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP3.03%0.59%1,735,00013,4200.78%18,425,700Mar 31, 2024
OCTAGON CAPITAL ADVISORS LP0.79%0.58%455,000405,000810.00%4,832,100Mar 31, 2024
NEWTYN MANAGEMENT, LLC0.29%0.35%165,000-481,760-74.49%1,752,300Mar 31, 2024
SIMPLIFY ASSET MANAGEMENT INC.0.91%0.33%521,935284,000119.36%5,542,950Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.03%0.18%19,38019,380100.00%205,816Mar 31, 2024
GILDER GAGNON HOWE & CO LLC1.78%0.14%1,017,617-437,515-30.07%10,807,093Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC1.00%0.13%572,3363600.06%6,078,208Mar 31, 2024

The largest Phathom Pharmaceuticals shareholder by % of total assets is MEDICXI VENTURES MANAGEMENT (JERSEY) LTD. The company owns 7.46M shares of Phathom Pharmaceuticals (PHAT), representing 17.65% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD13.03%17.65%7,464,5723,703,70398.48%79,273,755Mar 31, 2024
JENNISON ASSOCIATES LLC2.88%0.01%1,647,6971,647,697100.00%17,498,542Mar 31, 2024
PROPEL BIO MANAGEMENT, LLC1.52%5.38%869,927426,88096.35%9,238,625Mar 31, 2024
OCTAGON CAPITAL ADVISORS LP0.79%0.58%455,000405,000810.00%4,832,100Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC2.88%1.28%1,650,000370,00028.91%17,523,000Mar 31, 2024
SATURN V CAPITAL MANAGEMENT LLC0.87%2.13%500,987340,912212.97%5,320,482Mar 31, 2024
EAGLE ASSET MANAGEMENT INC0.53%0.02%304,839304,839100.00%3,231,293Mar 31, 2024
SIMPLIFY ASSET MANAGEMENT INC.0.91%0.33%521,935284,000119.36%5,542,950Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.82%0.01%467,448200,59175.17%4,964,298Mar 31, 2024
CITADEL ADVISORS LLC0.22%0.00%125,645114,112989.44%1,334,350Mar 31, 2024
MORGAN STANLEY0.41%0.00%237,160112,60990.41%2,518,640Mar 31, 2024
GHOST TREE CAPITAL, LLC0.85%1.43%485,00099,75925.90%5,150,700Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.78%3.16%445,16185,71523.85%4,727,610Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.25%0.01%144,70083,700137.21%1,536,714Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.39%0.00%223,39068,99944.69%2,372,401Mar 31, 2024
BLACKROCK INC.4.79%0.00%2,745,38066,4892.48%29,155,935Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.10%0.00%59,43759,437100.00%631,221Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.39%0.00%225,02454,98032.33%2,389,755Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.09%0.00%49,70049,700100.00%527,814Mar 31, 2024
STATE STREET CORP1.25%0.00%717,20129,3644.27%7,616,675Mar 31, 2024

As of Mar 31 2024, Phathom Pharmaceuticals's largest institutional buyer is MEDICXI VENTURES MANAGEMENT (JERSEY) LTD. The company purchased 3.70M stocks of PHAT, valued at $79.27M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JACOBS LEVY EQUITY MANAGEMENT, INC0.04%0.00%20,987-572,764-96.47%222,882Mar 31, 2024
WOODLINE PARTNERS LP0.99%0.06%566,439-529,682-48.32%6,015,582Mar 31, 2024
NEWTYN MANAGEMENT, LLC0.29%0.35%165,000-481,760-74.49%1,752,300Mar 31, 2024
GILDER GAGNON HOWE & CO LLC1.78%0.14%1,017,617-437,515-30.07%10,807,093Mar 31, 2024
WALLEYE CAPITAL LLC----202,154-100.00%-Mar 31, 2024
ECOR1 CAPITAL, LLC----198,480-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----82,244-100.00%-Mar 31, 2024
BIOIMPACT CAPITAL LLC----70,000-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----65,600-100.00%-Mar 31, 2024
D. E. SHAW & CO., INC.0.11%0.00%64,138-65,251-50.43%681,146Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.46%0.00%262,048-42,561-13.97%2,782,950Mar 31, 2024
JANE STREET GROUP, LLC0.04%0.00%25,021-40,233-61.66%265,723Mar 31, 2024
RUSSELL INVESTMENTS GROUP, LTD.----39,292-100.00%-Mar 31, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO----38,569-100.00%-Mar 31, 2024
BARCLAYS PLC0.05%0.00%28,199-21,473-43.23%300,000Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----20,619-100.00%-Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC----18,427-100.00%-Mar 31, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.----18,100-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----15,000-100.00%-Mar 31, 2024
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.----14,940-100.00%-Mar 31, 2024

As of Mar 31 2024, Phathom Pharmaceuticals's biggest institutional seller is JACOBS LEVY EQUITY MANAGEMENT, INC. The company sold -0.57M shares of PHAT, valued at $222.88K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JENNISON ASSOCIATES LLC2.88%0.01%1,647,6971,647,697100.00%17,498,542Mar 31, 2024
EAGLE ASSET MANAGEMENT INC0.53%0.02%304,839304,839100.00%3,231,293Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.10%0.00%59,43759,437100.00%631,221Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.09%0.00%49,70049,700100.00%527,814Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.04%0.01%22,04422,044100.00%234,107Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.03%0.18%19,38019,380100.00%205,816Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.02%-14,10014,100100.00%149,742Mar 31, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM0.02%0.00%11,22811,228100.00%80,168Mar 31, 2024
KLINGMAN & ASSOCIATES, LLC0.02%0.01%10,37610,376100.00%110,194Mar 31, 2024
KESTRA PRIVATE WEALTH SERVICES, LLC0.02%0.00%10,00010,000100.00%106,200Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC0.01%0.03%5,0005,000100.00%53,000Mar 31, 2024
RIGGS ASSET MANAGMENT CO. INC.0.00%0.00%6969100.00%733Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--77100.00%74Mar 31, 2024

Phathom Pharmaceuticals's largest new institutional shareholder by number of shares is JENNISON ASSOCIATES LLC, purchased 1.65M shares, valued at $17.50M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC----202,154-100.00%-Mar 31, 2024
ECOR1 CAPITAL, LLC----198,480-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----82,244-100.00%-Mar 31, 2024
BIOIMPACT CAPITAL LLC----70,000-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----65,600-100.00%-Mar 31, 2024
RUSSELL INVESTMENTS GROUP, LTD.----39,292-100.00%-Mar 31, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO----38,569-100.00%-Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----20,619-100.00%-Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC----18,427-100.00%-Mar 31, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.----18,100-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----15,000-100.00%-Mar 31, 2024
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.----14,940-100.00%-Mar 31, 2024
ALGERT GLOBAL LLC----14,920-100.00%-Mar 31, 2024
QUEST PARTNERS LLC----2,205-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----1,545-100.00%-Mar 31, 2024
TRADITION WEALTH MANAGEMENT, LLC----500-100.00%-Mar 31, 2024

Phathom Pharmaceuticals's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -0.20M shares, valued at -, as of undefined.

Phathom Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
PRUDENTIAL SECTOR FUNDS, INC.0.20%417,422417,422-Feb 29, 2024
Federated Hermes MDT Series0.06%159,626--Jan 31, 2024
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.05%1,733,665-11,709-0.67%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.05%25,360--Dec 31, 2023
STATE STREET INSTITUTIONAL FUNDS0.03%24,051--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.02%154,200--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,00462814.35%Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%56,2533,8987.45%Dec 31, 2023
AMG Funds IV0.01%19,748-200-1.00%Jan 31, 2024
ETFis Series Trust I0.01%9,1891,44518.66%Jan 31, 2024
VANGUARD INDEX FUNDS0.00%2,139,866548,31834.45%Dec 31, 2023
Nushares ETF Trust0.00%32,960-494-1.48%Jan 31, 2024
Fidelity Commonwealth Trust II0.00%22,84022,840-Aug 31, 2023
Voya PARTNERS INC0.00%229,901--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%575--Dec 31, 2023
Humankind Benefit Corp0.00%54--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%331,76710,4773.26%Feb 29, 2024
JANUS INVESTMENT FUND0.00%421,939--Dec 31, 2023
MASSMUTUAL PREMIER FUNDS0.00%36,710-2,526-6.44%Dec 31, 2023
Calvert Variable Products, Inc.0.00%3,095--Dec 31, 2023
VANGUARD EXPLORER FUND0.00%15,061--Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%3,968--Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%181,70815,4219.27%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%24,407--Dec 31, 2023
OHIO NATIONAL FUND INC0.00%14,533--Dec 31, 2023
Principal Exchange-Traded Funds0.00%6,953-572-7.60%Mar 31, 2024
Chartwell Funds0.00%11,6136,503127.26%Jun 30, 2022
NATIONWIDE VARIABLE INSURANCE TRUST0.00%61,97952,379545.61%Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%12,843--Dec 31, 2023
VANGUARD WORLD FUND0.00%97,0603,9834.28%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,676-580-25.71%Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%764--Dec 31, 2023
Trust for Advised Portfolios0.00%5,101--Dec 31, 2023
MFS VARIABLE INSURANCE TRUST III0.00%4,093--Dec 31, 2023
EQ ADVISORS TRUST0.00%226,90410,6834.94%Dec 31, 2023
Fidelity Rutland Square Trust II0.00%229,213--Feb 29, 2024
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%393,717-268-0.07%Dec 31, 2023
SunAmerica Specialty Series0.00%89--Apr 30, 2021
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,638-254-13.42%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%10,700--Dec 31, 2023
PUTNAM ASSET ALLOCATION FUNDS0.00%252--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%1,939--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%121,56916,07315.24%Dec 31, 2023
RUSSELL INVESTMENT FUNDS0.00%5,6353,385150.44%Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%142,43721,63017.90%Feb 29, 2024
SA FUNDS INVESTMENT TRUST0.00%1,013--Dec 31, 2023
RYDEX SERIES FUNDS0.00%225--Dec 31, 2023
ProFunds0.00%45718769.26%Jan 31, 2024
VANGUARD WELLINGTON FUND0.00%19,548--Feb 29, 2024
MUTUAL FUND SERIES TRUST0.00%160,000--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%14,1348,784164.19%Jan 31, 2024
VALIC Co I0.00%12,3054083.43%Feb 29, 2024
PACIFIC FUNDS SERIES TRUST0.00%11,488--Mar 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%37,997--Jan 31, 2024
Meeder Funds0.00%177--Mar 31, 2024
PROSHARES TRUST0.00%8,9741,36117.88%Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%111--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%3,535-45-1.26%Jan 31, 2024
PENN SERIES FUNDS INC0.00%700--Dec 29, 2023
GOLDMAN SACHS TRUST0.00%3,864--Feb 29, 2024
RBB FUND, INC.0.00%2,157--Feb 29, 2024
HC CAPITAL TRUST0.00%678--Dec 31, 2023
Brighthouse Funds Trust I0.00%219,817-455-0.21%Dec 31, 2023
Guggenheim Active Allocation Fund0.00%120--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%39,142--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%1,525--Dec 31, 2023
Direxion Shares ETF Trust0.00%2,511--Jan 31, 2024
NORTHERN FUNDS0.00%13,582--Dec 29, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%800--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%15--Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%26,100--Dec 31, 2023
SPDR INDEX SHARES FUNDS0.00%2,103180.86%Dec 31, 2023
PGIM ETF TRUST0.00%736--Feb 29, 2024
John Hancock Funds II0.00%161,865-4,165-2.51%Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,080--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%3,6331213.45%Jan 31, 2024
Brinker Capital Destinations Trust0.00%578--Feb 29, 2024
Goldman Sachs ETF Trust0.00%807-6,856-89.47%Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%748--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%1,52654054.77%Feb 29, 2024
Brighthouse Funds Trust II0.00%10,477--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%11,481--Dec 31, 2023
PACIFIC SELECT FUND0.00%11,811-359-2.95%Dec 31, 2023
Dimensional ETF Trust0.00%982--Jan 31, 2024
Advisors' Inner Circle Fund III0.00%32--Jan 31, 2024
SPDR SERIES TRUST0.00%69,960--Dec 31, 2023
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%360--Feb 29, 2024
Bridge Builder Trust0.00%10,831--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%1,564--Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%4,039--Dec 31, 2023
COLUMBIA FUNDS SERIES TRUST I0.00%3,997-69,014-94.53%Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%5,900--Feb 29, 2024

Phathom Pharmaceuticals's largest mutual fund holder by % of total assets is "PRUDENTIAL SECTOR FUNDS, INC.", owning 417.42K shares, compromising 0.20% of its total assets.

Phathom Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24117-0.85%
31 Dec, 231186.31%
30 Sep, 231115.71%
30 Jun, 2310523.53%
31 Mar, 2385-2.30%
31 Dec, 2287-
30 Sep, 2287-4.40%
30 Jun, 229110.98%
31 Mar, 2282-1.20%
31 Dec, 2183-
30 Sep, 21837.79%
30 Jun, 2177-7.23%
31 Mar, 218312.16%
31 Dec, 207429.82%
30 Sep, 2057-5.00%
30 Jun, 206027.66%
31 Mar, 204714.63%
31 Dec, 1941-

As of 31 Mar 24, 117 institutions are holding Phathom Pharmaceuticals's shares, representing a decrease of -0.85% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2452,249,16712.12%
31 Dec, 2346,601,2626.49%
30 Sep, 2343,760,2702.45%
30 Jun, 2342,715,45839.41%
31 Mar, 2330,640,4788.11%
31 Dec, 2228,341,867-6.03%
30 Sep, 2230,162,03210.31%
30 Jun, 2227,342,1906.42%
31 Mar, 2225,692,967-10.08%
31 Dec, 2128,574,49511.87%
30 Sep, 2125,543,6862.51%
30 Jun, 2124,919,0051.92%
31 Mar, 2124,449,375-0.25%
31 Dec, 2024,509,90913.30%
30 Sep, 2021,631,992-0.99%
30 Jun, 2021,847,194-0.47%
31 Mar, 2021,949,5390.63%
31 Dec, 1921,811,276-

Phathom Pharmaceuticals (PHAT) has 52.25M shares outstanding as of 31 Mar 24, up 12.12% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2491.19%1.35%
31 Dec, 2382.07%1.01%
30 Sep, 2390.23%0.89%
30 Jun, 23100.85%1.93%
31 Mar, 2372.34%1.54%
31 Dec, 2268.61%1.14%
30 Sep, 2277.70%1.52%
30 Jun, 2271.44%1.57%
31 Mar, 2267.55%1.13%
31 Dec, 2177.22%1.65%
30 Sep, 2168.48%1.48%
30 Jun, 2168.02%1.50%
31 Mar, 2167.36%1.30%
31 Dec, 2071.96%1.71%
30 Sep, 2064.83%1.48%
30 Jun, 2066.21%1.45%
31 Mar, 2067.60%1.50%
31 Dec, 1967.17%-

As of 31 Mar 24, Phathom Pharmaceuticals is held by 91.19% institutional shareholders, representing a 1.35% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2453-28.38%
31 Dec, 237417.46%
30 Sep, 2363-7.35%
30 Jun, 236844.68%
31 Mar, 234720.51%
31 Dec, 2239-17.02%
30 Sep, 2247-7.84%
30 Jun, 225115.91%
31 Mar, 2244-13.73%
31 Dec, 215150.00%
30 Sep, 2134-24.44%
30 Jun, 21457.14%
31 Mar, 2142-6.67%
31 Dec, 2045221.43%
30 Sep, 2014-65.00%
30 Jun, 204053.85%
31 Mar, 2026-36.59%
31 Dec, 1941-

53 institutional shareholders have increased their position in PHAT stock as of 31 Mar 24 compared to 74 in the previous quarter (a -28.38% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 243454.55%
31 Dec, 2322-4.35%
30 Sep, 232321.05%
30 Jun, 2319-
31 Mar, 2319-24.00%
31 Dec, 22254.17%
30 Sep, 22249.09%
30 Jun, 2222-8.33%
31 Mar, 222484.62%
31 Dec, 2113-43.48%
30 Sep, 212364.29%
30 Jun, 2114-39.13%
31 Mar, 212353.33%
31 Dec, 2015-34.78%
30 Sep, 2023228.57%
30 Jun, 207-41.67%
31 Mar, 2012-
31 Dec, 19--

34 institutional shareholders have reduced their position in PHAT stock as of 31 Mar 24 compared to 22 in the previous quarter (a 54.55% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24117-0.85%52,249,16712.12%91.19%1.35%53-28.38%3454.55%
31 Dec, 231186.31%46,601,2626.49%82.07%1.01%7417.46%22-4.35%
30 Sep, 231115.71%43,760,2702.45%90.23%0.89%63-7.35%2321.05%
30 Jun, 2310523.53%42,715,45839.41%100.85%1.93%6844.68%19-
31 Mar, 2385-2.30%30,640,4788.11%72.34%1.54%4720.51%19-24.00%
31 Dec, 2287-28,341,867-6.03%68.61%1.14%39-17.02%254.17%
30 Sep, 2287-4.40%30,162,03210.31%77.70%1.52%47-7.84%249.09%
30 Jun, 229110.98%27,342,1906.42%71.44%1.57%5115.91%22-8.33%
31 Mar, 2282-1.20%25,692,967-10.08%67.55%1.13%44-13.73%2484.62%
31 Dec, 2183-28,574,49511.87%77.22%1.65%5150.00%13-43.48%
30 Sep, 21837.79%25,543,6862.51%68.48%1.48%34-24.44%2364.29%
30 Jun, 2177-7.23%24,919,0051.92%68.02%1.50%457.14%14-39.13%
31 Mar, 218312.16%24,449,375-0.25%67.36%1.30%42-6.67%2353.33%
31 Dec, 207429.82%24,509,90913.30%71.96%1.71%45221.43%15-34.78%
30 Sep, 2057-5.00%21,631,992-0.99%64.83%1.48%14-65.00%23228.57%
30 Jun, 206027.66%21,847,194-0.47%66.21%1.45%4053.85%7-41.67%
31 Mar, 204714.63%21,949,5390.63%67.60%1.50%26-36.59%12-
31 Dec, 1941-21,811,276-67.17%-41---

Phathom Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Henderson Mollyofficer CFO and CBOS-SaleSell3,435$11.10$38.13K95,263
Mar 26, 2024Curran Terriedirector, officer President and Chief ExecutiveS-SaleSell16,851$9.11$153.51K410,784
Jan 25, 2024TAKEDA PHARMACEUTICAL CO LTD10 percent owner-S-SaleSell3,703,703$8.10$30.00M3,755,583
Jan 22, 2024Henderson Mollyofficer CFO and CBOS-SaleSell6,307$7.75$48.90K98,698
Nov 21, 2023Henderson Mollyofficer CFO and CBOS-SaleSell2,127$7.24$15.40K103,061
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy2,500$7.80$19.50K55,000
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy4,000$7.76$31.04K52,500
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy1,000$8.04$8.04K48,500
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell811$7.80$6.33K116,869
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell11,681$8.95$104.54K105,188

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy2,500$7.80$19.50K55,000
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy4,000$7.76$31.04K52,500
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy1,000$8.04$8.04K48,500

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Henderson Mollyofficer CFO and CBOS-SaleSell3,435$11.10$38.13K95,263
Mar 26, 2024Curran Terriedirector, officer President and Chief ExecutiveS-SaleSell16,851$9.11$153.51K410,784
Jan 25, 2024TAKEDA PHARMACEUTICAL CO LTD10 percent owner-S-SaleSell3,703,703$8.10$30.00M3,755,583
Jan 22, 2024Henderson Mollyofficer CFO and CBOS-SaleSell6,307$7.75$48.90K98,698
Nov 21, 2023Henderson Mollyofficer CFO and CBOS-SaleSell2,127$7.24$15.40K103,061
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell811$7.80$6.33K116,869
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell11,681$8.95$104.54K105,188

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Henderson Mollyofficer CFO and CBOS-SaleSell3,435$11.10$38.13K95,263
Mar 26, 2024Curran Terriedirector, officer President and Chief ExecutiveS-SaleSell16,851$9.11$153.51K410,784
Jan 26, 2024Medicxi Ventures Management (Jersey) Ltd10 percent owner-Buy---3,673,602
Jan 26, 2024Medicxi Ventures Management (Jersey) Ltd10 percent owner-Buy---3,641,728
Jan 26, 2024Medicxi Ventures Management (Jersey) Ltd10 percent owner-Buy---87,267
Jan 26, 2024Medicxi Ventures Management (Jersey) Ltd10 percent owner-Buy---61,975
Jan 25, 2024TAKEDA PHARMACEUTICAL CO LTD10 percent owner-S-SaleSell3,703,703$8.10$30.00M3,755,583
Jan 22, 2024Henderson Mollyofficer CFO and CBOA-AwardBuy120,000$7.60$912.00K120,000
Jan 22, 2024Henderson Mollyofficer CFO and CBOS-SaleSell6,307$7.75$48.90K98,698
Jan 22, 2024Nabulsi Azmiofficer Chief Operating OfficerA-AwardBuy130,000$7.60$988.00K130,000
Jan 22, 2024Curran Terriedirector, officer President and Chief ExecutiveA-AwardBuy475,000$7.60$3.61M475,000
Nov 21, 2023Henderson Mollyofficer CFO and CBOS-SaleSell2,127$7.24$15.40K103,061
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy2,500$7.80$19.50K55,000
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy4,000$7.76$31.04K52,500
Nov 08, 2023Parikh Asitdirector-P-PurchaseBuy1,000$8.04$8.04K48,500
Nov 03, 2023Henderson Mollyofficer CFO and CBOA-AwardBuy22,500--117,680
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell811$7.80$6.33K116,869
Nov 03, 2023Henderson Mollyofficer CFO and CBOS-SaleSell11,681$8.95$104.54K105,188
Nov 03, 2023Nabulsi Azmiofficer Chief Operating OfficerA-AwardBuy32,500--242,067
Nov 03, 2023Curran Terriedirector, officer President and Chief ExecutiveA-AwardBuy37,500--427,171

The last insider sell of Phathom Pharmaceuticals's stock was made by Henderson Molly on Apr 10 2024, selling 3,435 shares at $11.10 per share (valued at $38.13K). The last insider buy of PHAT was made by Parikh Asit on Nov 08 2023, buying 2,500 shares at $7.80 per share (worth $19.50K).

Phathom Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 202433100.00%
Q4 202363200.00%
Q3 202344100.00%
Q2 2023184450.00%
Q1 202383266.67%
Q4 2022-2-
Q3 20224--
Q2 202223--
Q1 202272350.00%
Q4 20211520.00%
Q3 20211812.50%
Q2 20216748.11%
Q1 202143212.50%
Q4 2020-21-
Q3 20203--
Q2 202062300.00%
Q1 20203475.00%
Q4 201971258.33%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Phathom Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 2024-3-
Q4 202333100.00%
Q3 2023---
Q2 202333100.00%
Q1 20232366.67%
Q4 2022-2-
Q3 2022---
Q2 20225--
Q1 2022-1-
Q4 2021-4-
Q3 2021-8-
Q2 2021-70-
Q1 2021-31-
Q4 2020-21-
Q3 2020---
Q2 20201--
Q1 20202450.00%
Q4 20194--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Phathom Pharmaceuticals's stocks.

Phathom Pharmaceuticals Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
CNSPCNS Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
VECTVectivBio Holding AG
XFORX4 Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
IMMXImmix Biopharma, Inc.
DAWNDay One Biopharmaceuticals, Inc.
GPCRStructure Therapeutics Inc.
CGEMCullinan Oncology, Inc.
AMLXAmylyx Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
KNSAKiniksa Pharmaceuticals, Ltd.
AVROAVROBIO, Inc.
HEPAHepion Pharmaceuticals, Inc.
KRTXKaruna Therapeutics, Inc.
LYRALyra Therapeutics, Inc.

PHAT Ownership FAQ


Phathom Pharmaceuticals is owned by institutional shareholders (91.19%), insiders (9.07%), and public (-0.27%). The largest institutional shareholder of Phathom Pharmaceuticals is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. (17.64% of total shares) and the top mutual fund owner is PRUDENTIAL SECTOR FUNDS, INC. (0.20% of total shares).

Phathom Pharmaceuticals's major institutional shareholders are FRAZIER LIFE SCIENCES MANAGEMENT, L.P., MEDICXI VENTURES MANAGEMENT (JERSEY) LTD, CARLYLE GROUP INC., INVESCO LTD., and BLACKROCK INC.. The top five shareholders own together 47.08% of the company's share outstanding.

As of Mar 2024, there are 117 institutional shareholders of Phathom Pharmaceuticals.

FRAZIER LIFE SCIENCES MANAGEMENT, L.P owns 10.11M shares of Phathom Pharmaceuticals, representing 17.64% of the company's total shares outstanding, valued at $107.36M (as of Mar 2024).

As of Mar 2024, MEDICXI VENTURES MANAGEMENT (JERSEY) LTD holds 7.46M shares of Phathom Pharmaceuticals (PHAT), compromising 13.03% of the company, valued at $79.27M.

CARLYLE GROUP INC is the third largest holder of Phathom Pharmaceuticals. The company owns 3.5M of the company's shares outstanding (worth $37.1M).